Tue, January 4, 2022
Mon, January 3, 2022
Sun, January 2, 2022
Fri, December 31, 2021
Thu, December 30, 2021
Wed, December 29, 2021
Tue, December 28, 2021
Mon, December 27, 2021
Thu, December 23, 2021
Wed, December 22, 2021
Tue, December 21, 2021
Mon, December 20, 2021
Fri, December 17, 2021
Thu, December 16, 2021

Jason Butler Maintained (ACAD) at Buy with Increased Target to $42 on, Dec 21st, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-42-on-dec-21st-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Jason Butler of JMP Securities, Maintained "ACADIA Pharmaceuticals Inc." (ACAD) at Buy with Increased Target from $39 to $42 on, Dec 21st, 2021.

Jason has made no other calls on ACAD in the last 4 months.



There are 4 other peers that have a rating on ACAD. Out of the 4 peers that are also analyzing ACAD, all agree with Jason's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jay Olson of "Oppenheimer" Maintained at Hold with Increased Target to $23 on, Thursday, December 9th, 2021
  • Salveen Richter of "Goldman Sachs" Maintained at Hold with Increased Target to $28 on, Wednesday, December 8th, 2021
  • Vamil Divan of "Mizuho" Maintained at Hold with Increased Target to $26 on, Tuesday, December 7th, 2021
  • Jeffrey Hung of "Morgan Stanley" Maintained at Hold with Increased Target to $24 on, Tuesday, December 7th, 2021

Publication Contributing Sources